Middle Molecule Find

Rulebook › V-tags › V337

V337 Blood path integrity test between uses

Written V0337 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD47:2002/A1:2003, adopted by reference at 42 CFR 494.50(b)(1) · Appendix H Rev. 246, page 158 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR § 494.50(b)(1)

11.3.3 Blood path integrity test

A membrane integrity test such as an air pressure leak test shall be done between uses.

Read 42 CFR 494.50 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.50(b)(1)

AAMI Rationale for the Development and Provisions of this Recommended Practice

A.11.3.3 Blood path integrity test

The 1986 edition of the AAMI recommended practice did not include a blood path integrity test. Following recommendations from the Centers for Disease Control and Prevention (CDC), the AAMI RDD Committee agreed to add this test to the second edition of the recommended practice. This test is based on the observation that only a small amount of air leaks through wetted membranes, resulting in a pressure drop of less than 10% of the test pressure. A maximum allowable pressure drop is not given because of variations among test systems and dialyzers.

Additional Guidance:

Recognize that manual reprocessing systems may require each dialyzer be tested separately. Automated systems must include the pressure leak test in the method and apparatus used for testing the integrity a dialyzer prior to its reuse.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 158 (the full 469-page PDF) before quoting it.